Repression of malignant tumor progression upon pharmacologic IGF1R blockade in a mouse model of insulinoma

Molecular Cancer Research : MCR
Adrian ZumstegGerhard Christofori

Abstract

NVP-AEW541, a specific ATP-competitive inhibitor of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase, has been reported to interfere with tumor growth in various tumor transplantation models. We have assessed the efficacy of NVP-AEW541 in repressing tumor growth and tumor progression in the Rip1Tag2 transgenic mouse model of pancreatic β-cell carcinogenesis. In addition, we have tested NVP-AEW541 in Rip1Tag2;RipIGF1R double-transgenic mice which show accelerated tumor growth and increased tumor malignancy compared with Rip1Tag2 single-transgenic mice. Previously, we have shown that high levels of IGF-2, a high-affinity ligand for IGF1R, are required for Rip1Tag2 tumor cell survival and tumor growth. Unexpectedly, treatment of Rip1Tag2 mice with NVP-AEW541 in prevention and intervention trials neither did affect tumor growth nor tumor cell proliferation and apoptosis. Yet, it significantly repressed progression to tumor malignancy, that is, the rate of the transition from differentiated adenoma to invasive carcinoma. Treatment of Rip1Tag2;RipIGF1R double-transgenic mice resulted in moderately reduced tumor volumes and increased rates of tumor cell apoptosis. Sustained expression of IGF-2 and of the IGF-2-binding...Continue Reading

References

Mar 1, 1992·Diabetologia·I Swenne
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·S EfratS Baekkeskov
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C SellR Baserga
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·J DiGiovanniC Conti
Aug 16, 2001·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ingo Burtscher, Gerhard Christofori
Mar 31, 2004·Cancer Cell·Carlos García-EcheverríaFrancesco Hofmann
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·G Sakuntala Warshamana-GreeneGeoffrey W Krystal
Aug 2, 2005·Drug Discovery Today·Francesco Hofmann, Carlos García-Echeverría
Nov 23, 2005·Gynecologic Oncology·Walter H GotliebMichael N Pollak
Jan 25, 2006·Clinical Endocrinology·P J JenkinsS M Shalet
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Barbara TannoGiuseppe Raschellà
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria C ManaraKatia Scotlandi
May 4, 2007·The Journal of Clinical Investigation·Antonio Sica, Vincenzo Bronte
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Meenali M ChitnisValentine M Macaulay
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Feb 27, 2009·Future Oncology·Renato Baserga
Oct 3, 2009·Trends in Biochemical Sciences·James BrownBriony E Forbes
May 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Danielle B UlanetDouglas Hanahan
Oct 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G Maki

❮ Previous
Next ❯

Citations

May 9, 2014·PloS One·Ramadevi SubramaniRajkumar Lakshmanaswamy
Apr 22, 2015·Seminars in Cancer Biology·Mark A FeitelsonSomaira Nowsheen
Aug 12, 2015·Molecular and Cellular Endocrinology·Run Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved